Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Deep phenotyping of human induced pluripotent stem cell–derived atrial and ventricular cardiomyocytes
Lukas Cyganek, … , Gerd Hasenfuss, Kaomei Guan
Lukas Cyganek, … , Gerd Hasenfuss, Kaomei Guan
Published June 21, 2018
Citation Information: JCI Insight. 2018;3(12):e99941. https://doi.org/10.1172/jci.insight.99941.
View: Text | PDF
Research Article Muscle biology Stem cells

Deep phenotyping of human induced pluripotent stem cell–derived atrial and ventricular cardiomyocytes

  • Text
  • PDF
Abstract

Generation of homogeneous populations of subtype-specific cardiomyocytes (CMs) derived from human induced pluripotent stem cells (iPSCs) and their comprehensive phenotyping is crucial for a better understanding of the subtype-related disease mechanisms and as tools for the development of chamber-specific drugs. The goals of this study were to apply a simple and efficient method for differentiation of iPSCs into defined functional CM subtypes in feeder-free conditions and to obtain a comprehensive understanding of the molecular, cell biological, and functional properties of atrial and ventricular iPSC-CMs on both the single-cell and engineered heart muscle (EHM) level. By a stage-specific activation of retinoic acid signaling in monolayer-based and well-defined culture, we showed that cardiac progenitors can be directed towards a highly homogeneous population of atrial CMs. By combining the transcriptome and proteome profiling of the iPSC-CM subtypes with functional characterizations via optical action potential and calcium imaging, and with contractile analyses in EHM, we demonstrated that atrial and ventricular iPSC-CMs and -EHM highly correspond to the atrial and ventricular heart muscle, respectively. This study provides a comprehensive understanding of the molecular and functional identities characteristic of atrial and ventricular iPSC-CMs and -EHM and supports their suitability in disease modeling and chamber-specific drug screening.

Authors

Lukas Cyganek, Malte Tiburcy, Karolina Sekeres, Kathleen Gerstenberg, Hanibal Bohnenberger, Christof Lenz, Sarah Henze, Michael Stauske, Gabriela Salinas, Wolfram-Hubertus Zimmermann, Gerd Hasenfuss, Kaomei Guan

×

Figure 2

Structural characterization of iPSC-derived atrial or ventricular cardiomyocytes.

Options: View larger image (or click on image) Download as PowerPoint
Structural characterization of iPSC-derived atrial or ventricular cardio...
(A) Immunofluorescence staining data of retinoic acid–treated (RA-treated) and untreated iPSC-derived cardiomyocyte (iPSC-CMs) cultures for F-actin (phalloidin), MLC2V, and MLC2A (iPSC line iWT.D2.1, day 86); nuclei were stained with DAPI (white). Scale bar: 50 μm. (B) Structural characterization via immunofluorescence staining for F-actin, α-actinin, MLC2V, MLC2A, gap junction protein CX43, and sarcoplasmic reticulum calcium channel RYR2 (iPSC lines iWT.D2.1 and isWT1.Bld2); nuclei were stained with DAPI (white). Scale bar: 20 μm. (C) Quantification of MLC2V+ and MLC2A+ cells in immunofluorescently stained cultures (n = 15 control and n = 11 RA-treated independent differentiation experiments from 3 iPSC lines, days 80–120). Data are presented as mean ± SEM. ****P < 0.0001 by nonparametric Mann-Whitney U test. (D) Western blot analysis for general cardiac marker cardiac troponin T (cTNT) and subtype markers MLC2V and MLC2A at days 60 and 90 (iPSC line iWT.D2.1).

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts